Radiofrequency Neurolysis denials in California external review
In the California DMHC record, independent physician reviewers decided 51 published external-review cases involving Radiofrequency Neurolysisand overturned the plan’s denial in 33.3%. That is a historical result among cases that reached this program, not a forecast for an individual appeal.
Conditions behind Radiofrequency Neurolysis denials
| Category | Decisions | Overturned |
|---|---|---|
| Sacroiliac Joint Pain | 5 | 0% |
| Low Back Pain | 4 | 50% |
| Sacroiliac Joint Dysfunction | 3 | 33.3% |
| Lumbar Radiculopathy | 3 | 0% |
| Sacroiliitis | 3 | 0% |
What the reviewers wrote
Where the denial was overturned
Nature of Statutory Criteria/Case Summary: An enrollee has requested radiofrequency neurolysis for treatment of the enrollee’s mid and lower back pain. Findings: Two physician reviewers found that the request for radiofrequency neurolysis is likely to be more beneficial for treatment of the patient’s medical condition than any available standard therapy. There is medical literature supporting the utility of thoracic facet radiofrequency neurolysis for the treatment of pain due to thoracic facet pain. Hegarty performed a 12-month retrospective observational evaluation of adults treated with radiofrequency (RF) for refractory sacroiliac joint syndrome (SIJ).
Nature of Statutory Criteria/Case Summary: An enrollee has requested reimbursement for radiofrequency neurolysis/ablation. Review of the literature with comprehensive analysis of the published data pertaining to the effectiveness and risks of fluoroscopically guided cervical medial branch thermal radiofrequency neurotomy for treating chronic neck pain of zygoapophyseal joint origin. The authors concluded that if performed as described in the International Spine Intervention Society guidelines, fluoroscopically guided cervical medial branch thermal radiofrequency neurotomy is effective for cervical zygoapophyseal joint pain and carries only minor risks. This patient complains primarily of severe left-sided neck pain with radiation to the shoulders and head. The provider does not document any evidence of radiculopathy.
Where the denial was upheld
Nature of Statutory Criteria/Case Summary: An enrollee has requested authorization and coverage for radiofrequency neurolysis for treatment of the enrollee’s recurrent back pain. Findings: Two physician reviewers found that the patient was status post L4/5 microdiscectomy. The treating provider’s report indicated that the patient received one week of pain relief following the caudal and left L5 transforaminal epidural steroid injections. She reported that she also had pain on the right and left lumbar areas with burning and shooting pain down her legs. She felt like her back and legs were going to give out. A lumbar spine examination documented normal alignment and no tenderness to palpation. Range of motion was documented as flexion 90 degrees, extension 15 degrees, and negative straight leg raise at 70 degrees. Lower extremity neurologic examination was reported within normal limits.
A 48-year-old female enrollee has requested authorization and coverage for radiofrequency neurolysis for treatment of the enrollee’s chronic pain. Findings: Two physician reviewers found that the patient has chronic low back pain. She is status post posterior lumbar fusion at L4-5 and intrathecal pump placement for chronic low back pain. The patient’s medications include oxycodone, Baclofen, and intrathecal bupivacaine. Sacroiliac joint injections were performed, which reportedly resulted in more than 50% reduction in her pain.
Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California external-review outcomes. Other state and federal programs have different eligibility rules, processes, and current availability; the rates here do not transfer to those programs or predict an individual result. Excerpts are quoted verbatim from the public record and describe this treatment generally, not any individual case.
These outcomes describe eligible cases completed through California DMHC’s Independent Medical Review program. They do not estimate the chance that an internal appeal, an external review in another jurisdiction, or your individual case will succeed. Use the record to identify evidence patterns involving Radiofrequency Neurolysis, then check the rights and deadlines that apply to your plan.
SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · AGGREGATES + DEIDENTIFIED DECISION EXCERPTS/REFERENCE IDS · METHODOLOGY